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First person – Mathias Cobbaut and Ahmed Elbediwy
First Person is a series of interviews with the first authors of a selection
of papers published in Journal of Cell Science, helping early-career
researchers promote themselves alongside their papers. Mathias
Cobbaut and Ahmed Elbediwy are co-first authors on ‘The Rho family
GEF FARP2 is activated by aPKCι to control tight junction formation
and polarity’, published in JCS. Mathias is a postdoc in the lab of
Prof. Peter Parker at The Francis Crick Institute, London, investigating
protein kinase regulation/biochemistry and the functional role of
protein kinase signaling. Ahmed is a lecturer at Kingston University,
investigating cancer biology, polarity and signaling.
How would you explain the main findings of your paper in
lay terms?
MC and AE: For cells to develop into functional tissues, they need
to be correctly positioned. In epithelial tissues, individual cells need
to know their ‘top’ and their ‘bottom’, because these two sides of the
cell have unique properties and this is known as cell polarity. If you
think of a magnet, for instance, it has two poles, and a cell is very
similar. In this article, we identified a role for the protein FARP2 in
cell polarization. Specifically, we found that FARP2 acts as an
activator for Cdc42, a protein that is essential for polarity. Cdc42
works with another protein called aPKC to establish cellular
polarization and to allow cells to stick to each other in a process
called cell–cell adhesion. We found that aPKC modifies FARP2,
which seems to drive its correct localization and complex turnover at
cell–cell junctions to establish junction formation and maintenance.
Were there any specific challenges associated with this
project? If so, how did you overcome them?
MC and AE: The challenges in this project were on the
mechanistic level. Initially, we hypothesized that aPKC-mediated
phosphorylation of FARP2 would modulate its activity to increase
active Cdc42 levels in a positive-feedback-loop mechanism. That
would have been a straightforward answer and matched the
observed phenotype seen with non-phosphorylatable mutants of
FARP2. However, the picture seemed to be more complicated.
FARP2 phosphorylation did not affect the overall levels of active
Cdc42; rather, we found that phosphorylation mediates correct
localization of FARP2 to the tight junction compartment and
enhances aPKC–FARP2 complex turnover in order to liberate
FARP2 to activate local pools of Cdc42. Untangling this
mechanism was quite the challenge in this project, but we do like
these mechanistic puzzles, so in the end, it was quite rewarding
to solve it!
When doing the research, did you have a particular result or
‘eureka’ moment that has stuck with you?
MC: I would say that the eureka moment within this project was
when we uncovered the mechanistic consequence of FARP2
phosphorylation and put the pieces of the puzzle together to draft
an optimized model.
AE: I also think another eureka moment was earlier in the project
when we observed how effective the FARP2 phenotype was in
comparison to FARP1.
Why did you choose Journal of Cell Science for your paper?
AE: As one of the leading cell biology journals, it was clear that
we wanted our novel research to be published in JCS. With over
150 years of experience in publishing groundbreaking papers, it was
the obvious choice.
Have you had any significant mentors who have helped
you beyond supervision in the lab? How was their
guidance special?
MC: I would like to mention Peter Parker’s mentorship, since his
constant support and his ideas for different hypotheses helped to
shape this paper (but also my work in general). My joint first
co-author Ahmed has also been a great example to me in this
process. Ahmed would never let his drive and enthusiasm diminish.
He is like a pitbull biting a bone; once something is of value to him,
hewill not release it, which is an inspiring attitude, I have to say. In a
more general sense, I have to mention my PhD supervisor and
co-supervisor, Johan Van Lint and Veerle Janssens at the KU
Leuven (Belgium), who have been very supportive of me, not only
with regards to career choices and establishing connections, but also
in exposing me to the wider cell signaling field, helping me to
understand the ‘people factor’ in science, and channeling my
enthusiasm towards good research. Finally, the general mentoring
environment of the Francis Crick Institute is very inspiring. The
institute has been built to nurture informal scientific discussion with
Mathias Cobbaut
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a variety of inspirational people that are on top of their game,
studying versatile research topics. It is hard not to be swept up by the
energy that radiates out of this building!
AE: I would also like to give credit to Peter Parker for allowing me
to collaborate with his lab on this amazing project. The other person
I wish to mention is of course my joint first co-author Mathias.
He has recently started as a postdoc and his tenacity and resilience
are outstanding. He would be working late into the night, as well as
over the weekend, having dinner at his desk just to make sure
the experiment he is performing is perfect. He has a bright
future ahead.
What motivated you to pursue a career in science, and what
have been themost interestingmoments on the path that led
you to where you are now?
MC: I have always been fascinated by the degree of complexity in
the world that surrounds us, but the decision to pursue science as a
career was mainly inspired by my high school biology classes
around the age of sixteen, where I first came into in-depth contact
with molecular biology and biochemistry. I was fascinated by the
elegant chemical mechanisms by which life is organized and how
even subtle defects in the system could lead to disease. On top of
that, we had a very inspirational teacher, which I feel is crucially
important for pupils in choosing a STEM career! I am happy with
my scientific path to date, especially the support I have had from
people along the way. It has been a very interesting, challenging and
rewarding period. Some of the interesting moments along the way
I would say are: the excitement about the first discovery of
something new and ‘weird’ that has driven me since; my first
conference in the field, where I was able to meet all the ‘rock stars’
I had been reading and hearing so much about; the first paper we
successfully published; and the first time I went abroad for a
placement. It has all been valuable and has nurtured me to the point
where I am now.
AE: The idea of trying to answer a question and investigating the
problem is what made me want to do research. There have been
many interesting things along the way. One Sunday early in my
PhD, I needed some buffer, andmy supervisor bought a 20 litre box-
style bottle which was on its side – the idea being to unscrew the top
and screw on the tap. I tried this while the box was on its side; 20
litres later, I walked – soaked and dripping – to the toilet to dry
myself using the hand dryer.
“Research is like a marathon, you will
find a few bumps on the way, but if you
persevere you will succeed.”
Who are your role models in science? Why?
MC: At heart, I’m a kinase biochemist, so I look up to the godfathers
and mothers in the kinase field. Examples include Susan Taylor,
who crystallized the first kinase (PKA) and has since done a
tremendous and relentless job to uncover every detail of its
mechanism of action, and Tony Hunter, the discoverer of crucially
important Tyr and, recently, His phosphorylation. Both of them
were very approachable and supportive when I had the opportunity
to meet them. Also chemical biologists, such Jason Chin, whose
innovative work blewme away once in a keynote lecture, and Kevan
Shokat, whose innovations have been crucial to the kinase chemical
genetics field. Both are very inspirational. In general, I look up to
scientists who are excited by solid scientific discoveries, even if they
are discomforting to their own work. I can also safely say that Peter
Parker has been a role model for me, not only for his seminal
scientific work in the PKC field but also regarding his management
style, which leaves a lot of breathing room for his people to pursue
their personal interests within projects and keep their motivation
levels high.
Ahmed Elbediwy
Staining of apical cell polarity proteins that provide a scaffolding function
for various signaling molecules.
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What’s next for you?
MC: I am at the beginning of my first postdoc so there are many
future possibilities depending on my achievements and the contacts
that I will establish.
AE: I am currently a lecturer at Kingston University, so I am starting
to build my research group and hopefully I will be able to carry
forward my research interests on polarity and signaling.
Tell us something interesting about yourself thatwouldn’t be
on your CV
MC: As a proud Belgian, I have a keen interest in brewing and
subsequently sampling beer.
AE: I’m a proud Liverpool and Egypt national team supporter.
Football is a great way to relax after a hard day of research. I also
have two football-mad kids who keep me busy!
What advice would you give to a scientist starting out on the
path of research?
AE: Research is like a marathon, you will find a few bumps on the
way, but if you persevere you will succeed. Therewill be days where
things don’t work and you feel like giving up, but keep going and
the clouds will lift and the sun will shine.
MC: Never lose your curiosity and sense of amazement.
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